Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis

NCT01590966 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Axial and Peripheral Spondyloarthritis
Rheumatoid Arthritis

Interventions

DRUG: administration of Cimzia®
DRUG: Immunoscintigraphy with radiolabeled Cimzia®.

Sponsor

University Hospital, Ghent

Collaborators

[object Object]